Health Care & Life Sciences » Pharmaceuticals | Midatech Pharma PLC

Midatech Pharma PLC | Cash Flow

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,663.00
8,822.00
10,099.00
20,162.00
16,064.00
15,030
Depreciation, Depletion & Amortization
116.00
322.00
737.00
4,355.00
2,560.00
1,111
Other Funds
761.00
1,778.00
2,120.00
2,932.00
1,904.00
1,356
Funds from Operations
1,786.00
6,722.00
11,482.00
12,875.00
11,612.00
12,582
Changes in Working Capital
34.00
1,227.00
891.00
121.00
1,437.00
1,453
Net Operating Cash Flow
1,752.00
5,495.00
12,373.00
12,996.00
13,049.00
14,035
Capital Expenditures
138.00
1,030.00
925.00
1,366.00
1,485.00
Sale of Fixed Assets & Businesses
-
115.00
1,867.00
-
-
Net Investing Cash Flow
138.00
915.00
1,586.00
1,366.00
1,485.00
Issuance/Reduction of Debt, Net
2,157.00
496.00
214.00
239.00
4,660.00
Net Financing Cash Flow
2,167.00
34,348.00
214.00
15,329.00
10,388.00
Net Change in Cash
277.00
27,938.00
14,150.00
1,433.00
4,404.00
Free Cash Flow
1,890.00
6,525.00
13,295.00
14,343.00
13,756.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
12.00
19
Net Assets from Acquisitions
-
-
2,528.00
-
-
Change in Capital Stock
10.00
33,852.00
-
15,568.00
5,728.00
Exchange Rate Effect
-
-
23.00
466.00
258.00

About Midatech Pharma

View Profile
Address
Oddfellows House
Cardiff Cardiff CF24 0AA
United Kingdom
Employees -
Website http://midatechpharma.com/
Updated 07/08/2019
Midatech Pharma Plc commercializes oncology treatments and cancer supportive care products through its U. S. commercial organization, Midatech Pharma US.